PDB2 A PHARMACOECONOMIC EVALUATION FOR DIABETES TYPE 2 (DM 2) PATIENTS WITH INHIBITORS OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ANDTHIAZOLIDINEDIONES (TZD) AS ADD-ONTHERAPY

Autor: Fon, F, Celaya, JM, Ayala, C, Antunez, O, Garcia-Contreras, F
Zdroj: In Value in Health 2007 10(6):A254-A254
Databáze: ScienceDirect